AI Simulations Aim to Predict Drug Trial Failures
Artificial intelligence is emerging as a potential tool to help pharmaceutical companies predict whether experimental drugs are likely to succeed before costly human trials. Novartis shares fell 11% after its late-stage trial of experimental...
U.S. Launches $5 Billion AI Initiative to Accelerate Scientific Research
The Trump administration has announced a $5 billion initiative to tackle long-standing scientific challenges using artificial intelligence across multiple fields. The program will involve 15 federal agencies, including the Departments of Health and Human...





